Labcorp Holdings Inc. (BMV:LH)

Market Cap	415.69B
Revenue (ttm)	269.33B
Net Income (ttm)	14.94B
Shares Out	n/a
EPS (ttm)	177.16
PE Ratio	27.83
Forward PE	16.37
Dividend	57.34 (1.17%)
Ex-Dividend Date	May 29, 2025

Volume	23
Average Volume	478
Open	4,905.73
Previous Close	4,879.29
Day's Range	4,905.73 - 4,905.73
52-Week Range	3,985.00 - 5,336.44
Beta	n/a
RSI	57.98
Earnings Date	Jul 24, 2025

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 70,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: LH

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD